Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test

by | Nov 20, 2025 | Stock Market

Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences.

Article Attribution | Read More at Article Source